Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (KCT0012335) titled 'Phase IV clinical trial to evaluate the efficacy and safety of Glucom solution in subjects with physical fatigue' on July 27.

Study Type: Interventional Study

Study Design: Primary Purpose : Treatment, Intervention Model : Parallel, Blinding/Masking : Double, Blinding Target : Subject, Investigator, Allocation : RCT

Primary Sponsor: Korean Drug

Condition:

Endocrine, nutritional and metabolic diseases

Intervention: Drug : After subjects who had experienced physical fatigue lasting for more than one month voluntarily provided written consent for this clinical trial, the principal investigator randomized subjects w...